Cargando…

A Novel Fully Human Agonistic Single Chain Fragment Variable Antibody Targeting Death Receptor 5 with Potent Antitumor Activity In Vitro and In Vivo

Agonistic antibodies, which bind specifically to death receptor 5 (DR5), can trigger apoptosis in tumor cells through the extrinsic pathway. In this present study, we describe the use of a phage display to isolate a novel fully human agonistic single chain fragment variable (scFv) antibody, which ta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lei, Gaoxin, Xu, Menglong, Xu, Zhipan, Gu, Lili, Lu, Chenchen, Bai, Zhengli, Wang, Yue, Zhang, Yongbo, Hu, Huajing, Jiang, Yiwei, Zhao, Wenfeng, Tan, Shuhua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5666746/ https://www.ncbi.nlm.nih.gov/pubmed/28953230 http://dx.doi.org/10.3390/ijms18102064

Ejemplares similares

Development of a novel, fully human, anti-PCSK9 antibody with potent hypolipidemic activity by utilizing phage display-based strategy
por: Xu, Menglong, et al.
Publicado: (2021)

Enhancement of antitumor activity by using a fully human gene encoding a single-chain fragmented antibody specific for carcinoembryonic antigen
por: Shibaguchi, Hirotomo, et al.
Publicado: (2017)

Generation of a Novel High-Affinity Antibody Binding to PCSK9 Catalytic Domain with Slow Dissociation Rate by CDR-Grafting, Alanine Scanning and Saturated Site-Directed Mutagenesis for Favorably Treating Hypercholesterolemia
por: Bai, Zhengli, et al.
Publicado: (2021)

Lunasin Improves the LDL-C Lowering Efficacy of Simvastatin via Inhibiting PCSK9 Expression in Hepatocytes and ApoE(−/−) Mice
por: Gu, Lili, et al.
Publicado: (2019)

Lunasin functionally enhances LDL uptake via inhibiting PCSK9 and enhancing LDLR expression in vitro and in vivo
por: Gu, Lili, et al.
Publicado: (2017)

Bactericidal fully human single‐chain fragment variable antibodies protect mice against methicillin‐resistant Staphylococcus aureus bacteraemia
por: Soltanmohammadi, Behnoush, et al.
Publicado: (2021)

Development of a fully human anti‐GITR antibody with potent antitumor activity using H2L2 mice
por: Tong, Qiuli, et al.
Publicado: (2022)

Potent antitumoral activity of TRAIL through generation of tumor-targeted single-chain fusion proteins
por: Schneider, B, et al.
Publicado: (2010)

Successful engineering of a highly potent single-chain variable-fragment (scFv) bispecific antibody to target disialoganglioside (GD2) positive tumors
por: Cheng, Ming, et al.
Publicado: (2016)

A humanized 4-1BB-targeting agonistic antibody exerts potent antitumor activity in colorectal cancer without systemic toxicity
por: Cheng, Lian-sheng, et al.
Publicado: (2022)

Novel Site-Specific Fatty Chain-Modified GLP-1 Receptor Agonist with Potent Antidiabetic Effects
por: Zhong, Xia, et al.
Publicado: (2019)

OX40‐targeted immune agonist antibodies induce potent antitumor immune responses without inducing liver damage in mice
por: Tee, Yee C., et al.
Publicado: (2021)

A systemically administered detoxified TLR4 agonist displays potent antitumor activity and an acceptable tolerance profile in preclinical models
por: Chettab, Kamel, et al.
Publicado: (2023)

Identification of MSA-2: An oral antitumor non-nucleotide STING agonist
por: Liu, Jianhua, et al.
Publicado: (2021)

Potent antitumor property of Allium bakhtiaricum extracts
por: Vafaee, Kosar, et al.
Publicado: (2019)

Furan-Conjugated Tripeptides as Potent Antitumor Drugs
por: Ali, Hunain, et al.
Publicado: (2020)

An engineered oncolytic vaccinia virus encoding a single-chain variable fragment against TIGIT induces effective antitumor immunity and synergizes with PD-1 or LAG-3 blockade
por: Zuo, Shuguang, et al.
Publicado: (2021)

Eupafolin Exhibits Potent Anti-Angiogenic and Antitumor Activity in Hepatocellular Carcinoma
por: Jiang, Honglei, et al.
Publicado: (2017)

Potent Antitumor Activity Generated by a Novel Tumor Specific Cytotoxic T Cell
por: Wang, Zheng, et al.
Publicado: (2013)

In vitro and in vivo evaluation of a single chain antibody fragment generated in planta with potent rabies neutralisation activity
por: Phoolcharoen, Waranyoo, et al.
Publicado: (2019)

Multiple stimuli-responsive nanosystem for potent, ROS-amplifying, chemo-sonodynamic antitumor therapy
por: Tang, JunJie, et al.
Publicado: (2021)

IL-24-Armed Oncolytic Vaccinia Virus Exerts Potent Antitumor Effects via Multiple Pathways in Colorectal Cancer
por: Deng, Lili, et al.
Publicado: (2021)

Synthesis and biological evaluation of celastrol derivatives as potent antitumor agents with STAT3 inhibition
por: Xu, Shaohua, et al.
Publicado: (2021)

Discovery of a Novel Hybrid of Vorinostat and Riluzole as a Potent Antitumor Agent
por: Xu, Qifu, et al.
Publicado: (2020)

Single-Chain Fragment Variable Passive Immunotherapies for Neurodegenerative Diseases
por: Huang, Liang, et al.
Publicado: (2013)

Discovery of Novel Quinazoline Derivatives as Potent Antitumor Agents
por: Niu, Zhenxi, et al.
Publicado: (2022)

Thioridazine has potent antitumor effects on lung cancer stem-like cells
por: Shen, Jiani, et al.
Publicado: (2017)

Pharmacological Characterization of Dezocine, a Potent Analgesic Acting as a κ Partial Agonist and μ Partial Agonist
por: Wang, Yu-Hua, et al.
Publicado: (2018)

Introduction of Nonacidic Side Chains on 6-Ethylcholane Scaffolds in the Identification of Potent Bile Acid Receptor Agonists with Improved Pharmacokinetic Properties
por: Finamore, Claudia, et al.
Publicado: (2019)

Characterization of a new potent and long-lasting single chain peptide agonist of RXFP1 in cells and in vivo translational models
por: Illiano, Stephane, et al.
Publicado: (2022)

Fully conjugated azacorannulene dimer as large diaza[80]fullerene fragment
por: Wang, Weifan, et al.
Publicado: (2022)

Lycorine Displays Potent Antitumor Efficacy in Colon Carcinoma by Targeting STAT3
por: Wu, Song, et al.
Publicado: (2018)

Development and identification of fully human scFv-Fcs against Staphylococcus aureus
por: Nian, Siji, et al.
Publicado: (2016)

Human single-chain variable fragment that specifically targets arthritic cartilage
por: Hughes, Chris, et al.
Publicado: (2010)

Single-Chain Fragment Variable: Recent Progress in Cancer Diagnosis and Therapy
por: Muñoz-López, Paola, et al.
Publicado: (2022)

Potent Antitumor Effects of a Combination of Three Nutraceutical Compounds
por: Vishwakarma, Vikalp, et al.
Publicado: (2018)

Drug repurposing: Discovery of troxipide analogs as potent antitumor agents
por: Lu, Nan, et al.
Publicado: (2020)

Affinity improvement of the fully human anti-TSLP recombinant antibody
por: Chen, Qi, et al.
Publicado: (2020)

Molecular reshaping of phage-displayed Interleukin-2 at beta chain receptor interface to obtain potent super-agonists with improved developability profiles
por: Rojas, Gertrudis, et al.
Publicado: (2023)

Mechanism Exploration of Amyloid-β-42 Disaggregation by Single-Chain Variable Fragments of Alzheimer’s Disease Therapeutic Antibodies
por: Fan, Xing, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_j3r9sc6qactmhir4itgckvclnd